CBD Co. Overstated Revenue, Investor Suit Says
Canopy Growth Corp., which sells cannabis products for recreational and medical use, was hit with a proposed class action from an investor alleging that the company failed to disclose weaknesses in...To view the full article, register now.
Already a subscriber? Click here to view full article